{"transactions":[{"id":2399923,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":130546,"kind":"person","name":"Choy Gavin","position":1,"cik":"0001905561","reported_name":"Choy Gavin","relationship":{"officer":true,"officer_title":"Acting Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2022-02-14T21:09:22.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":227500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control."}],"balance_after":227500,"derivative":{"exercise_price":3.05,"expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":227500},"source":{"system":"sec-edgar","filing":"0001654954-22-001631","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000165495422001631/section16.xml","form_type":"4"}}]}